| [1] |
Arpino G, Bardou VJ, Clark GM, et al.Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome[J].Breast Cancer Res,2004,6(3):R149-R156.
|
| [2] |
Bharat A, Gao F, Margenthaler JA.Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers[J].Am J Surg,2009,198(4):516-519.
|
| [3] |
Glass AG, Lacey JV Jr, Carreon JD, et al.Breast cancer incidence,1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status[J].J Natl Cancer Inst,2007,99(15):1152-1161.
|
| [4] |
Wasif N, Maggard MA, Ko CY, et al.Invasive lobular vs.ductal breast cancer: a stage-matched comparison of outcomes[J].Ann Surg Oncol,2010,17(7):1862-1869.
|
| [5] |
Rakha EA, El-Sayed ME, Powe DG, et al.Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes[J].Eur J Cancer,2008,44(1):73-83.
|
| [6] |
Li CI, Daling JR, Malone KE, et al.Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer[J].Cancer Epidemiol Biomarkers Prev,2006,15(5):946-954.
|
| [7] |
吕明丽,张晟,刘红,等.双侧原发性乳腺癌ER、PR 及HER-2表达特征及其与预后的关系[J/CD].中华乳腺病杂志: 电子版,2009,3(1):32-40.
|
| [8] |
Caldarella A,Crocetti E,Bianchi S,et al.Female breast cancer status according to ER,PR and HER2 expression: a population based analysis [J].Pathol Oncol Res,2011,17 (3):753-758.
|
| [9] |
Bashir MA,Ali NA,Shaban S,et al.Young women in the UAE have higher incidence of HER2 positive breast cancer[J].Breast J,2012,18 (6):637-638.
|
| [10] |
Aleskandarany MA, Green AR, Benhasouna AA, et al.Prognostic value of proliferation assay in the luminal,HER2-positive,and triple-negative biologic classes of breast cancer[J].Breast Cancer Res,2012,14(1):R3.
|
| [11] |
MacCallum DE,Hall PA.The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle [J].J Pathology,2000,190(5):537-544.
|
| [12] |
Turashvili G, Bouchal J, Ehrmann J, et al.Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2007,151(1):59-64.
|
| [13] |
Esposito NN, Chivukula M, Dabbs DJ.The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: An immunohistochemical and clinicopathologic study[J].Mod Pathol,2007,20(1):130-138.
|
| [14] |
Smid M, Wang Y, Zhang Y, et al.Subtypes of breast cancer show preferential site of relapse[J].Cancer Res,2008,68(9):3108-3114.
|
| [15] |
Perou CM, Sorlie T, Eisen MB, et al.Molecular portraits of human breast tumors[J].Nature,2000,406(6797):747-752.
|